TCL Archive Clinical Biomarker Discovery Initiative would speed progress in early detection and measurement of response to therapy, Leland Hartwell tells NCI. November 12, 2004
TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive NCI to Support Research and Development Of Image Guided Therapy for Prostate Cancer July 16, 1999
TCL Archive FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds December 26, 2003
